Literature DB >> 15919081

Resveratrol-Cu(II) induced DNA breakage in human peripheral lymphocytes: implications for anticancer properties.

Asfar Sohail Azmi1, Showket Hussain Bhat, S M Hadi.   

Abstract

Resveratrol (3,4',5-trihydroxy stilbene), a plant derived polyphenol found in mulberries, grapes and red wine is considered to possess chemopreventive properties against cancer. It is recognized as a naturally occurring antioxidant but also catalyzes oxidative DNA degradation in vitro in the presence of transition metal ions such as copper. Using a cellular system of lymphocytes isolated from human peripheral blood and Comet assay, we have confirmed that resveratrol-Cu(II) system is indeed capable of causing DNA degradation in cells such as lymphocytes. Also, trans-stilbene, which does not have any hydroxyl groups, is inactive in the lymphocyte system. Pre-incubation of lymphocytes with resveratrol indicates that it is capable of either traversing the cell membrane or binding to it. Our results are in partial support of our hypothesis that anticancer properties of various plant derived polyphenols may involve mobilization of endogenous copper and the consequent prooxidant action.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919081     DOI: 10.1016/j.febslet.2005.04.077

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  27 in total

1.  Resveratrol-induced apoptosis is enhanced in low pH environments associated with cancer.

Authors:  Uzma Shamim; Sarmad Hanif; Abdulmajeed Albanyan; Frances W J Beck; Bin Bao; Zhiwei Wang; Sanjeev Banerjee; Fazlul H Sarkar; Ramzi M Mohammad; Sheikh M Hadi; Asfar S Azmi
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

2.  White light-mediated Cu (II)-5FU interaction augments the chemotherapeutic potential of 5-FU: an in vitro study.

Authors:  Sandesh Chibber; Mohd Farhan; Iftekhar Hassan; Imrana Naseem
Journal:  Tumour Biol       Date:  2011-05-27

Review 3.  Resveratrol mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for chemoprevention of cancer.

Authors:  S M Hadi; M F Ullah; A S Azmi; A Ahmad; U Shamim; H Zubair; H Y Khan
Journal:  Pharm Res       Date:  2010-01-30       Impact factor: 4.200

4.  DNA breakage induced by piceatannol and copper(II): Mechanism and anticancer properties.

Authors:  Zhensheng Li; Xiaozhan Yang; Shiwu Dong; Xiaohui Li
Journal:  Oncol Lett       Date:  2012-02-09       Impact factor: 2.967

Review 5.  Understanding the Prooxidant Action of Plant Polyphenols in the Cellular Microenvironment of Malignant Cells: Role of Copper and Therapeutic Implications.

Authors:  Mohd Farhan; Asim Rizvi
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

Review 6.  Multifaceted approach to resveratrol bioactivity: Focus on antioxidant action, cell signaling and safety.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Oxid Med Cell Longev       Date:  2010 Mar-Apr       Impact factor: 6.543

7.  Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia.

Authors:  Monika Podhorecka; Dorota Halicka; Piotr Klimek; Malgorzata Kowal; Sylwia Chocholska; Anna Dmoszynska
Journal:  Ann Hematol       Date:  2010-08-17       Impact factor: 3.673

8.  Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells.

Authors:  Praveen Rajendran; Emily Ho; David E Williams; Roderick H Dashwood
Journal:  Clin Epigenetics       Date:  2011-10-26       Impact factor: 6.551

9.  Resveratrol antibacterial activity against Escherichia coli is mediated by Z-ring formation inhibition via suppression of FtsZ expression.

Authors:  Dahyun Hwang; Young-Hee Lim
Journal:  Sci Rep       Date:  2015-05-05       Impact factor: 4.379

10.  Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage.

Authors:  Hongmei Luo; Aimin Yang; Bradley A Schulte; Michael J Wargovich; Gavin Y Wang
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.